Is this the fabled 6th indication? I assume it is. We were told it was a neurological condition. The resolution with the university of Munster allowed it to progress to a n=6 trial possibly later this year.
Ann: afamelanotide in fair-skinned Parkinsons patients, page-11
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.94 |
Change
0.820(5.42%) |
Mkt cap ! $791.7M | |||
| Open | High | Low | Value | Volume |
| $15.12 | $15.99 | $15.12 | $1.941M | 123.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 201 | $15.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.94 | 171 | 5 |
View Market Depth
| Last trade - 14.51pm 13/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |